Waste segregation, classification and disposal compliance for API operations

Waste segregation, classification and disposal compliance for API operations Waste Segregation, Classification and Disposal Compliance for API Operations The pharmaceutical industry has increasingly recognized the importance of sustainability and environmental compliance within its manufacturing processes. This article serves as a comprehensive guide for professionals in the pharmaceutical sector, focusing on waste segregation, classification, and disposal compliance specifically in Active Pharmaceutical Ingredient (API) operations. It aligns with the principles of green chemistry, emphasizing solvent selection, waste reduction, and adherence to regulatory standards set by the US FDA and relevant authorities in the UK and EU. Understanding Waste Segregation in API Operations…

Continue Reading... Waste segregation, classification and disposal compliance for API operations

Greener nitration, halogenation and metal-catalysed steps in API chemistry

Greener nitration, halogenation and metal-catalysed steps in API chemistry Greener Nitration, Halogenation and Metal-Catalysed Steps in API Chemistry Introduction to Green Chemistry in API Production As regulatory standards evolve to encourage sustainable practices, the integration of green chemistry principles in Active Pharmaceutical Ingredient (API) production becomes increasingly critical. With the U.S. FDA at the forefront, pharmaceutical professionals are tasked with optimizing production methods to meet stringent guidelines for waste reduction and environmental impact. The goal is not just to comply with regulations but also to embrace a paradigm shift towards sustainable manufacturing. This tutorial provides a step-by-step guide focused on…

Continue Reading... Greener nitration, halogenation and metal-catalysed steps in API chemistry

Supplier collaboration on greener reagents and solvents for API intermediates

Supplier collaboration on greener reagents and solvents for API intermediates Supplier Collaboration on Greener Reagents and Solvents for API Intermediates In the rapidly evolving pharmaceutical industry, the push for sustainability has become more pronounced than ever, particularly within the realm of Active Pharmaceutical Ingredient (API) production. Regulatory stakeholders, including the FDA, are increasingly focusing on the adoption of green chemistry principles, solvent selection strategies, and waste reduction techniques as essential components of compliant and efficient manufacturing processes. This article outlines a structured approach for pharmaceutical professionals to successfully engage suppliers in adopting greener practices in the production of API intermediates….

Continue Reading... Supplier collaboration on greener reagents and solvents for API intermediates

How to document green chemistry changes in NDA, ANDA and post-approval filings

How to document green chemistry changes in NDA, ANDA and post-approval filings How to Document Green Chemistry Changes in NDA, ANDA, and Post-Approval Filings In the evolving landscape of pharmaceutical manufacturing and development, the integration of green chemistry principles is becoming increasingly critical. As regulatory agencies, including the FDA, emphasize sustainability, pharmaceutical professionals must ensure that changes related to green chemistry are adequately documented in New Drug Applications (NDAs), Abbreviated New Drug Applications (ANDAs), and during post-approval modifications. This guide aims to provide a comprehensive, step-by-step tutorial on how to document such changes while remaining compliant with FDA regulations. Understanding…

Continue Reading... How to document green chemistry changes in NDA, ANDA and post-approval filings

Waste minimisation and by-product valorisation opportunities in API synthesis

Waste Minimisation and By-Product Valorisation Opportunities in API Synthesis The pharmaceutical industry is increasingly recognizing the importance of sustainability in Active Pharmaceutical Ingredient (API) production. With rising environmental awareness and regulatory scrutiny, understanding waste minimisation and by-product valorisation is crucial for pharmaceutical professionals. This article provides a comprehensive, step-by-step guide on incorporating green chemistry principles into API synthesis while complying with U.S. FDA regulations. Increased efficiency and reduced waste not only meet regulatory requirements but also support corporate social responsibility goals. Understanding Green Chemistry in API Production Green chemistry is defined as the design of chemical products and processes that…

Continue Reading... Waste minimisation and by-product valorisation opportunities in API synthesis

Regulatory inspection talking points when presenting greener API processes

Regulatory Inspection Talking Points When Presenting Greener API Processes Introduction to Green Chemistry in API Production The pharmaceutical industry is increasingly under pressure to adopt sustainable practices, particularly in the area of active pharmaceutical ingredient (API) production. This trend is driven by regulatory agencies, environmental concerns, and market demand for greener products. Green chemistry principles focus on reducing environmental impact through efficient processes and materials use. Emphasizing green chemistry during regulatory inspections can positively influence perceptions of a company’s compliance and commitment to sustainability. In this article, we will outline essential talking points and strategies for presenting greener API processes…

Continue Reading... Regulatory inspection talking points when presenting greener API processes

Making a business case for investing in greener API process development

Making a Business Case for Investing in Greener API Process Development Introduction to Green Chemistry in API Production In recent years, the pharmaceutical industry has increasingly focused on sustainability and the adoption of green chemistry principles to reduce environmental impact. The push towards greener Active Pharmaceutical Ingredient (API) production is not merely a trend but a necessary evolution. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) have shown interest in sustainable manufacturing practices as part of their broader commitment to ensuring public health and environmental safety. Green chemistry, defined by the Environmental Protection Agency (EPA), refers to…

Continue Reading... Making a business case for investing in greener API process development

Training development chemists on green chemistry principles for FDA programs

Training Development Chemists on Green Chemistry Principles for FDA Programs Training Development Chemists on Green Chemistry Principles for FDA Programs In recent years, green chemistry principles have gained traction within the regulatory frameworks overseen by the U.S. Food and Drug Administration (FDA). As the pharmaceutical industry confronts pressures to adopt sustainable practices, it is essential for development chemists working within FDA-regulated environments to understand and apply green chemistry principles effectively. This article outlines the key components of training development chemists in green chemistry, specifically focusing on API production, solvent selection, and waste reduction strategies. Understanding Green Chemistry in the Context…

Continue Reading... Training development chemists on green chemistry principles for FDA programs

Aligning green chemistry KPIs with cost of goods and supply chain resilience

Aligning Green Chemistry KPIs with Cost of Goods and Supply Chain Resilience In an increasingly competitive pharmaceutical sector, there is a heightened emphasis on sustainability both as a regulatory requirement and as a market differentiator. The integration of green chemistry principles into the API (Active Pharmaceutical Ingredient) production process can significantly enhance the efficiency of manufacturing operations while minimizing the environmental impact. This article provides a step-by-step tutorial focused on aligning green chemistry Key Performance Indicators (KPIs) with the cost of goods and supply chain resilience within FDA-regulated environments. Understanding Green Chemistry in Pharmaceutical Manufacturing Green chemistry is a set…

Continue Reading... Aligning green chemistry KPIs with cost of goods and supply chain resilience

Digital tools to model solvent usage, waste and carbon impact in API routes

Digital Tools to Model Solvent Usage, Waste and Carbon Impact in API Routes In the realm of pharmaceutical manufacturing, sustainability and compliance with U.S. Food and Drug Administration (FDA) guidelines are paramount. The rise of regulatory scrutiny and global environmental concerns has encouraged the adoption of green chemistry principles in Active Pharmaceutical Ingredient (API) production. This article serves as a comprehensive guide to understanding digital tools that can model solvent usage, waste generation, and carbon impact in API synthesis while remaining compliant with FDA regulations. Understanding Green Chemistry in FDA-Regulated Manufacturing Green chemistry refers to the design of chemical products…

Continue Reading... Digital tools to model solvent usage, waste and carbon impact in API routes